Effect of low‐dose vitamin D supplementation on uterine fibroid size in women with hypovitaminosis D: A nonrandomized pilot study
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70271 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Alba Orive und 6 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Ginecología, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Leiomyoma, Vitamin D Deficiency, Vitamin D, Uterine Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Objective
To evaluate the effect of low‐dose vitamin D supplementation on uterine fibroid (UF) size in patients with hypovitaminosis D.
Methods
This was a single‐center observational study including a prospective interventional cohort and a retrospective comparative cohort. The control group ( n = 16) included retrospective data from patients without vitamin D supplementation who attended two gynecological consultations 6 months apart. The interventional cohort ( n = 15) prospectively received low‐dose vitamin D supplementation (25 000 IU every 2 weeks for 6 months) and serum 25‐hydroxyvitamin D levels, UF size and vascularization, and patients' symptoms and quality of life were evaluated at baseline and 3 and 6 months.
Results
In untreated controls, UFs grew significantly in 6 months (67.1 ± 20.2 mm versus 79.4 ± 29.7 mm, P < 0.001). Vitamin D supplementation significantly reduced UFs from 56.9 ± 14.5 mm at baseline to 53.3 ± 13.3 mm after 3 months ( P = 0.03) and 52.2 ± 13.6 mm after 6 months ( P = 0.001). UF vascularity index (5.5 ± 7.5%) and vascularization flow index (2.2 ± 3.4) was significantly lower at month 6 compared with baseline (7.6 ± 9.9% [ P = 0.01] and 3.3 ± 5.4 [ P = 0.009], respectively).
Conclusion
Low‐dose vitamin D supplementation effectively reduced UF size in women with hypovitaminosis D within 6 months, suggesting vitamin D is a promising solution for patients with UFs and hypovitaminosis D. Clinical Trial Registration This study was registered on June 17, 2019, and the date of initial participant enrollment was July 9, 2019. NCT03991078, https://clinicaltrials.gov/study/NCT03991078 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Ginecología, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
- IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
- IVIRMA Global Research Alliance, IVIRMA Rome, Rome, Italy.
ORCID-Profile: Ana Corachán
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Orive, A., Corachán, A., Escrig, J., Mascarell-López, M. D. M., Pellicer, A., Monleón, J., & Ferrero, H. (2025). Effect of low‐dose vitamin D supplementation on uterine fibroid size in women with hypovitaminosis D: A nonrandomized pilot study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70271
Vancouver
Orive A, Corachán A, Escrig J, Mascarell-López MDM, Pellicer A, Monleón J, et al. Effect of low‐dose vitamin D supplementation on uterine fibroid size in women with hypovitaminosis D: A nonrandomized pilot study. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70271
BibTeX
@article{Orive2025,
author = {Orive, Alba and Corachán, Ana and Escrig, Julia and Mascarell-López, María Del Mar and Pellicer, Antonio and Monleón, Javier and Ferrero, Hortensia},
title = {Effect of low‐dose vitamin D supplementation on uterine fibroid size in women with hypovitaminosis D: A nonrandomized pilot study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70271}
}
EUVIMED